Life Science Analytics Market Size, Share & Growth Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Others), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer and Others) - Global Industry Analysis, Trends, Segment Forecasts, Regional Outlook 2023 - 2032

The global life science analytics market size was valued at USD 9.34 billion in 2022 and it is expected to hit over USD 24.12 billion by 2032, poised to grow at a CAGR of 8.63% from 2023 to 2032. U.S. life science analytics market was valued at USD 4.1 billion in 2022.

Life Science Analytics Market Size 2023 to 2032

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaway

  • By component, the services segment has accounted highest revenue share of 56% in 2022.
  • By type, the descriptive type segment has accounted revenue share of around 37% in 2022.
  • By application, the sales and marketing segment has held revenue share of 31.4% in 2022.
  • By delivery, the on-demand delivery segment has accounted for a revenue share of around 50.5% in 2022.
  • By end-user, the pharmaceutical segment has captured revenue share of around 47% in 2022.
  • In 2022, North America has generated revenue share of around 52% in 2022.

Technical upgradation in the field of analytics in the healthcare segment is considered as one of the major driving factors which promote the growth of the life science analytics market.

Furthermore, the rising penetration of big data usage in healthcare is also one of the prime factors for the life science care analytics segment. Data standardization coupled with firm investment in the field of data spending is further accelerating market growth. Rising burden of chronic disorders, increasing workloads on FDA and firm related to the drug approval process are some of the major reasons to support market growth. According to the National Health Council, in the year 2020 more than 157 million Americans are suffering from chronic disorders

Data analytics has always been known for its dealing with mass quantities of information in the various sectors. Increasing digitalization in hospitals, research centers are considered is the prime factor for the development of life science analytics market. Less price of data handling is the most prominent factor which assists in the development of the life science analytics market. Countries like United States, India, and China are experiencing huge amounts of patient data every day. Data-driven technology helps these countries to analyze the healthcare data like patient records, treatment, inventory management, staff data, and all other queries are at a much faster rate compare to the traditional method.

Some of the segments where life science analytics are much helpful are medical imaging, developing new therapies, smart staffing, reducing fraud, risk management, supply chain management and others.

Life Science Analytics Market Scope

Report Highlights Details
Market Size US$ 24.12 Billion by 2032
Growth Rate CAGR of 8.63% from 2023 to 2032
Base Year 2022
Historic Data 2020 to 2022
Forecast Period 2023 to 2032
Segments Covered Type, Component, Delivery Model, Application, End Users
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned SAS Institute Inc., Oracle Corporation, Accenture, IBM Corporation, Cognizant, IQVIA, Wipro, Cerner Corporation, MaxisIT, Optum, Microsoft, Infosys Limited


Type Insights

Different types of analytics assessed in this report are descriptive, predictive, diagnostic, discovery, and prescriptive. The descriptive segments held the majority of the market shares in the year 2022. Life science analytics always deals with the description methods to deals with the life sciences queries. For a better explanation and interpretations about the incidence and past trend data, the descriptive analytics provide overviews of the subjects. It is also observed that predictive health analytics proved to be more complex when compared with descriptive analytics. Most healthcare organizations aim to investigate the performance gap and allow the space for preparing the better strategies needed for the organization. Firm preference for descriptive analytics is due to its form or presentation like simple graphs with explanations. The discovery analytics used to discover or determine the different scientific facts. For instance, Centers for Medicare and Medicaid Services (CMS) used analytics to reduce hospital readmission rates.

The predictive analysis is registering growth at a CAGR of 9.2% over the forthcoming years.

Component Type Insights

Based on the type of component the market is fragmented into, software and services. In 2022, the services segment garnered for a revenue share of around 56%. Service provided by skilled professionals and cloud management services are costlier. These services are mostly provided by companies like Microsoft, clodera and others. The efficient running of the analytics services plays a major role in its execution. The services segment is poised to reach at a CAGR of 8.3% over the forecast period.

Application type Insights

By Application, the market is classified into research & development, supply chain optimization, clinical trials, sales & marketing, regulatory compliance, preclinical trials, and pharmacovigilance. The sales and marketing segment dominated the life science analytics market and garnered revenue share 31.4% in 2022.

Sales and marketing showed noticeable improvement in recent years and the same will grow at the considerable CAGR within the forecast period. Marketing campaigns and post-marketing surveys become important for the healthcare firm. Market surveillance is also assisted in boosting the life sciences analytics market.

The research and development is expected to hit at a CAGR of 9.9% over the forecast period.

End-users type Insights

On the basis of end-users, the market is classified into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. The pharmaceutical and bio-technology are the biggest end-users both in terms of revenue generation and consumption volume. In the year 2022, the same segment held the maximum market share 47%. Life science analytics is used to accelerate the process of discovery and development of the drugs, to optimize the efficacy of clinical trials, to focus on a specific population of the patients, to see the effect of the drug, to analyze the patient behavioral activities over healthcare outcome, and to further manage the patient's safety and risk management. For instance, The Johnson and Johnson Company is looking for the data to assist the pharmaceutical and biotechnological firm for making decision-based process easier.

Biotechnology companies are anticipated to reach at a CAGR of 8.8% over the forthcoming years.

Regional Insights

North America, Europe, Asia Pacific, Latin America and Middle East and Africa are the most common five region covered in the report of life science analytics market. North America is the appeared as dominant regional market among others. The North America region accounted largest revenue share of around 52%.

On the other hand, Asia Pacific is expanding at a CAGR of 10.5% over the forecast period. Major players of North America are looking towards the Asia Pacific for their future growth and development. Bulking loads of chronic disorders in the region like North America and Europe is also considered as one of the major driving factors which helps the growth of the global life science analytics market.

Life Science Analytics Market Companies

Major manufacturers in the global market are keen focusing on technological advancement in order to decreasing the cost of screening per patients. Some of the significant players in the Life science analytics market include:

  • SAS Institute Inc.
  • Oracle Corporation
  • Accenture
  • IBM Corporation
  • Cognizant, SCIO Health Analytics
  • Wipro
  • Allscripts Healthcare Solutions
  • Cerner Corporation
  • MaxisIT
  • Optum
  • Microsoft
  • Infosys Limited
  • Cotiviti
  • Others

Segments Covered in the Report

This research report estimates revenue growth at global, regional, and country levels and offers an analysis of present industry trends in every sub-segment from 2020 to 2032. This research study analyzes market thoroughly by classifying global Life science analytics market report on the basis of different parameters including type of type, application, component, application, delivery model, end users and region:

By Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics
  • Diagnostic Analytics
  • Discovery Analytics

By Component Type

  • Services
  • Software

By Delivery Model

  • On-premise model
  • On-demand model

By Application Type

  • Research & Development
  • Preclinical Trials
  • Clinical Trials
  • Sales & Marketing
  • Regulatory Compliance
  • Supply Chain Optimization
  • Pharmacovigilance

By End Users Type

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third-party Administrators

By Regional Outlook

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • Southeast Asia
  • Middle East and Africa
    • GCC
    • North Africa
    • South Africa
    • Rest of MEA

Frequently Asked Questions

What is the current size of the global life science analytics market?
Precedence Research Predicts, the global life science analytics market size was surpassed at USD 9.34 billion in 2022 and is expanding around USD 24.12 billion by 2030.
What is the CAGR of life science analytics market?
The global life science analytics market is registering impressive CAGR of 8.63% from 2023 to 2032.
What are the growth factors of life science analytics market?
The growth of the market is mainly associated with its application of advanced analytics. Recently, a high growth rate is seen in the healthcare and medical device sector which directly promotes the growth of the life science analytics market.
Which type segment was accounted largest market share in life science analytics market in 2022?
The descriptive segments held the majority of the market shares in the year 2022.
Which component type segment was hit major revenue share in life science analytics market in 2022?
The services segment seized major revenue share in the 2022.
Which region is dominant in the life science analytics market?
North America is the appeared as dominant regional market among others.
Which are the top key players of life sciences analytics market?
Some of the players of life sciences analytics market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Philips Healthcare, GE Healthcare, Becton, Dickinson and Company, QIAGEN N.V., Roche Diagnostics, Abbott Laboratories, Inc., Siemens Healthcare, C.R. Bard, Inc. and Others.
What is life sciences analytics?
Health care and life sciences analytics is a process of clinical data analysis that offer predictive tools for improved patient care. Analytics plays a lead role in the development of various sectors like healthcare, microbiology, and others. The role of analytics in the life-science is increasing day by day.


   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500


No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample